MedTrace Logo

Effectiveness of Pumpkin Seed Extract on Improving Blood Sugar Level in Subhealth Subjects

NCT05738655 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-02-23

No results posted yet for this study

Summary

This randomized, double-blind, placebo-controlled, and parallel clinical study aims to investigate the effectivness of a pumpkin seed extract on blood sugar management in subhealth people.

Conditions

Interventions

DIETARY_SUPPLEMENT

Pumpkin seed extract (Low dose)

Pumpkin seed extract standardized with specific peptides (300 mg/day)

DIETARY_SUPPLEMENT

Pumpkin seed extract (High dose)

Pumpkin seed extract standardized with specific peptides (600 mg/day)

DIETARY_SUPPLEMENT

Placebo

Placeo (300 mg/day)

Sponsors & Collaborators

  • Taipei Medical University

    collaborator OTHER

  • Greenyn Biotechnology Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Ming-Shun Wu, MD · WanFang Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-01
Primary Completion
2024-09-30
Completion
2024-10-31

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05738655 on ClinicalTrials.gov